Rivaroxaban Cuts Stroke Risk in HF Sans AF: Post Hoc COMMANDER-HF

Oral anticoagulation may have struck the right balance between stroke benefit and bleeding risk in systolic heart failure. Also, a stroke risk prediction tool may be more versatile than expected.
Medscape Medical News

Source link

Related posts

Why Synthetic Marijuana is So Risky


Sleep Disorder Drug May Be Effective for Stimulant Abuse


Hearing Aids May Reduce Cognitive Decline Risk


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World